Alisa Mall is leaving her role as managing director, investments for the Carnegie Corporation of New York to join a life sciences investment firm. Foresite Capital is bringing Alisa aboard as managing director, corporate strategy.
In that role, she will lead corporate development, long-term capital formation, investor relations and engagement on environmental, social and governance matters, according to publication Institutional Investor. Alisa was at Carnegie Corporation for more than 11 years.
During her time there, her responsibilities included managing the corporation’s real estate and natural resources portfolios as well as its inflation-linked strategies. Alisa is a past speaker at both the Women’s Private Equity Summit and the Women’s Alternative Investment Summit.
Her background also includes serving as a director in Tishman Speyer’s equity capital markets group and being an attorney at Orrick Herrington & Sutcliffe. Alisa’s departure from Carnegie follows two other recent departures at the philanthropic fund.
Kim Lew, who had been Carnegie’s chief investment officer, is now president and CEO of Columbia Investment Management Company, which manages Columbia University’s endowment. Additionally, Brooke Jones, who was managing director at Carnegie, became chief investment officer of Bryn Mawr College.